{"gene":"GRK6","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1993,"finding":"GRK6 was cloned as a 576-amino acid serine/threonine kinase that phosphorylates activated G protein-coupled receptors (β2-adrenergic receptor and rhodopsin) in a stimulus-dependent fashion, establishing it as a member of the GRK family with substrate specificity distinct from βARK and rhodopsin kinase.","method":"cDNA cloning, baculovirus overexpression in Sf9 cells, in vitro receptor phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation assay with purified protein, foundational cloning paper replicated by subsequent studies","pmids":["8366096"],"is_preprint":false},{"year":1994,"finding":"GRK6 is palmitoylated at a cluster of three C-terminal cysteines (Cys561, Cys562, Cys565) via a thioester bond, and this palmitoylation is essential for membrane association; palmitoylated GRK6 partitions exclusively to the membrane fraction.","method":"Metabolic labeling with [3H]palmitate, hydroxylamine treatment, HPLC, site-directed mutagenesis, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with mutagenesis, biochemical fractionation, and chemical verification of lipid linkage in single rigorous study","pmids":["7961702"],"is_preprint":false},{"year":1994,"finding":"Purified GRK6 phosphorylates rhodopsin, β2-adrenergic receptor, and m2 muscarinic receptor in a stimulus-dependent manner; GRK6 shares inhibition by heparin/dextran sulfate and preference for non-acidic peptide substrates with GRK5, but has lower stoichiometry on these receptors than GRK5 or βARK and does not undergo significant autophosphorylation.","method":"Protein purification (SP-Sepharose/heparin-Sepharose), in vitro kinase assays with receptor substrates and peptides, inhibitor titration","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzyme, multiple orthogonal substrate assays, rigorous biochemical characterization","pmids":["8077221"],"is_preprint":false},{"year":1997,"finding":"Palmitoylation of GRK6 is required for its membrane binding and activity toward receptor substrates: a palmitoylation-deficient mutant (Cys→Ser) shows ~5-fold higher Km and ~2-fold lower Vmax for rhodopsin and minimal β2-adrenergic receptor sequestration in COS-1 cells, while a geranylgeranylated GRK6 mutant (CAAX-tagged) shows enhanced membrane binding and ~14-fold higher Vmax.","method":"Site-directed mutagenesis, phospholipid vesicle binding assay, in vitro kinase assay, β2AR sequestration assay in COS-1 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with multiple orthogonal functional assays, replicated across cell-free and cellular systems","pmids":["9341194"],"is_preprint":false},{"year":1997,"finding":"Two GRK6 splice variants (GRK6a: 576 aa, GRK6b: 589 aa with a distinct C-terminal region due to a 2-bp intron insert) are expressed in rat tissues; GRK6a predominates in brain, GRK6b is more abundant in peripheral tissues; both isoforms phosphorylate light-activated rhodopsin and a synthetic peptide substrate.","method":"RT-PCR cloning, in vitro kinase assay with CHO cell cytosol extracts","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — functional assay confirmed for both isoforms but performed in crude cytosol extracts, single lab","pmids":["9316417"],"is_preprint":false},{"year":1998,"finding":"Palmitoylation of GRK6 increases its kinase catalytic activity intrinsically (beyond membrane localization): palmitoylated GRK6 is 10-fold more active than non-palmitoylated GRK6 at phosphorylating β2AR, and this elevated activity is also observed with the soluble substrate casein. Chemical depalmitoylation reduces casein phosphorylation activity, indicating palmitoylation directly enhances catalytic activity.","method":"Separation of palmitoylated vs. non-palmitoylated GRK6 fractions, in vitro kinase assays (β2AR and casein substrates), chemical depalmitoylation, geranylgeranylation rescue","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal substrate assays, chemical manipulation of palmitoylation state, single lab","pmids":["9819198"],"is_preprint":false},{"year":1999,"finding":"GRK6 autophosphorylates on Ser484 and Thr485 in vivo (in COS-7 cells), as revealed by electrophoretic mobility shift: catalytically inactive GRK6-K215R runs at 63 kDa (hypophosphorylated), while GRK6-K215R with S484D/T485D phosphomimetic mutations (GRK6-RDD) restores the 66 kDa mobility of wild-type GRK6. The C5a receptor (C5aR) is not a substrate for GRK6 in this system.","method":"Site-directed mutagenesis, SDS-PAGE mobility shift analysis, phosphatase treatment, overexpression in COS-7 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with electrophoretic evidence of autophosphorylation sites, two orthogonal approaches (mobility shift + phosphatase), single lab","pmids":["10334944"],"is_preprint":false},{"year":2002,"finding":"GRK6 plays a positive regulatory role in CXCL12 (SDF-1)-stimulated chemotaxis of T and B lymphocytes: GRK6-knockout mice show increased CXCL12-stimulated membrane GTPase activity (indicating impaired receptor desensitization) yet paradoxically impaired chemotaxis of T cells in transwell and transendothelial migration assays.","method":"GRK6-knockout mice, membrane GTPase activity assay, transwell migration assay, transendothelial migration assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mice, multiple orthogonal functional assays, parallel comparison with βarrestin2-KO and GRK5-KO controls","pmids":["12032308"],"is_preprint":false},{"year":2003,"finding":"GRK6 selectively desensitizes the secretin receptor in NG108-15 cells: overexpression of wild-type GRK6 reduces secretin-stimulated cAMP accumulation while dominant-negative GRK6 (K215R) enhances it, without affecting adenosine A2 or prostanoid IP receptor responses.","method":"Transient overexpression of WT and dominant-negative GRK6 in NG108-15 cells, cAMP accumulation assay","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative and wild-type overexpression with selective receptor specificity established, single lab","pmids":["12598420"],"is_preprint":false},{"year":2004,"finding":"GRK6 mediates desensitization of CXCR4 in neutrophils: GRK6-deficient neutrophils show enhanced SDF-1-induced chemotaxis in vitro and impaired desensitization of calcium responses to SDF-1; in vivo, GRK6-deficient mice have profoundly impaired G-CSF-induced neutrophil mobilization from bone marrow, attributed to enhanced CXCR4-mediated bone marrow retention.","method":"GRK6-knockout mice, in vitro chemotaxis assay (transwell), calcium flux assay, in vivo G-CSF treatment with blood neutrophil counting","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout model with multiple functional readouts (calcium, migration, in vivo mobilization) and mechanistic pathway placement","pmids":["14704365"],"is_preprint":false},{"year":2006,"finding":"Crystal structure of human GRK6 at 2.6 Å resolution reveals: (1) the catalytic core consists of intimately associated kinase and RGS homology (RGS-H) domains; (2) despite ATP analog binding, the kinase domain is in an open/inactive conformation, suggesting GPCRs activate GRKs by inducing kinase domain closure; (3) a putative phospholipid-binding site near the N-terminus; (4) structural elements in the substrate channel that influence GPCR access and specificity; (5) the RGS-H domain forms a dimer interface in the crystal using conserved hydrophobic residues, but dimerization is not required for receptor phosphorylation.","method":"X-ray crystallography (2.6 Å), structural comparison with GRK2, functional assays for dimerization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation of dimerization dispensability, defines second lineage of GRKs","pmids":["16613860"],"is_preprint":false},{"year":2009,"finding":"GRK6 fails to associate with WHIM-syndrome-associated mutant CXCR4 (lacking the C-terminal 19 residues) after ligand activation, while GRK3 associates normally; this impaired GRK6 recruitment correlates with delayed β-arrestin 2 recruitment, slower receptor internalization, and slower ERK1/2 activation, providing a molecular mechanism for CXCR4 dysfunction in WHIM syndrome.","method":"Co-immunoprecipitation of GRK6 and GRK3 with WT vs. WHIM-mutant CXCR4, β-arrestin recruitment assay, internalization assay, ERK activation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with two GRKs, correlated with functional downstream readouts, single lab","pmids":["19956569"],"is_preprint":false},{"year":2009,"finding":"GRK6 expression in multiple myeloma cells is stabilized by direct association with the HSP90 chaperone; GRK6 silencing suppresses STAT3 phosphorylation and reduces MCL1 levels and phosphorylation, causing selective lethality in myeloma cells.","method":"Co-immunoprecipitation (GRK6-HSP90 interaction), siRNA knockdown, Western blot for STAT3 phosphorylation and MCL1, cell viability assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for interaction, functional knockdown with defined signaling readouts, single lab","pmids":["19996089"],"is_preprint":false},{"year":2010,"finding":"GRK6 is recruited to the lyso-PC-activated G2A receptor in neutrophils (PMNs) as demonstrated by co-immunoprecipitation and digital microscopy, contributing to receptor desensitization as part of a signaling complex that also includes clathrin and β-arrestin-1.","method":"Co-immunoprecipitation, Western blot, subcellular fractionation, FRET-based digital microscopy","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and FRET evidence of recruitment, multiple imaging methods, single lab","pmids":["20799926"],"is_preprint":false},{"year":2013,"finding":"GRK6 promotes apoptotic cell clearance by cooperating with GIT1 to activate Rac1, enabling cytoskeletal rearrangement of phagocytes for engulfment; this pathway acts independently of the known DOCK180/ELMO/Rac1 and GULP1/Rac1 engulfment pathways. GRK6-deficient mice develop autoimmune disease and accumulate iron stores in splenic red pulp due to impaired senescent red blood cell clearance.","method":"GRK6-knockout mice, engulfment assays, co-immunoprecipitation (GRK6-GIT1), Rac1 activation assay, mass spectrometry, autoimmune phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mice with defined molecular mechanism (GRK6-GIT1-Rac1), epistasis with known pathways, multiple orthogonal functional readouts","pmids":["23443560"],"is_preprint":false},{"year":2014,"finding":"GRK6 mediates agonist-induced homologous phosphorylation of FFA4/GPR120 at Thr347, Ser350, and Ser357 in the C-terminal tail; concurrent mutation of these sites impairs β-arrestin-2 recruitment to the receptor membrane and enhances Gαq/11-mediated calcium responses.","method":"GRK6 overexpression/knockdown in HEK293 cells, phosphorylation site mutagenesis, β-arrestin-2 recruitment assay, calcium flux assay","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis of phosphorylation sites combined with functional signaling assays, single lab","pmids":["24412271"],"is_preprint":false},{"year":2015,"finding":"GRK6 directly phosphorylates IκBα at Ser32/Ser36 (the canonical NF-κB activation phosphorylation sites); GRK6 kinase activity is required for promoting NF-κB signaling after TNF-α stimulation; TNF-α induces a conformational change in GRK6 (monitored by BRET probe); GRK6 knockout in macrophages attenuates TNF-α-induced inflammatory gene transcription.","method":"In vitro kinase assay (GRK6 phosphorylating IκBα), kinase-dead mutant, BRET conformational sensor, GRK6-KO macrophages, inflammatory gene expression","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation of IκBα, mutagenesis, BRET, and KO functional validation; single lab but multiple orthogonal methods","pmids":["25881508"],"is_preprint":false},{"year":2016,"finding":"GRK6 interacts with and regulates phosphorylation of DNA-PKcs (DNA-dependent protein kinase, catalytic subunit); GRK6 knockout leads to impaired HSC self-renewal, lymphocytopenia, and loss of multiple hematopoietic progenitor populations, which are partially rescued by reactive oxygen species scavenger α-lipoic acid.","method":"GRK6-knockout mice, co-immunoprecipitation (GRK6-DNA-PKcs), Western blot for phosphorylation, transcriptome/proteomic analysis, α-lipoic acid rescue experiment","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for interaction, KO phenotype with pharmacological rescue, single lab","pmids":["27882944"],"is_preprint":false},{"year":2016,"finding":"GRK6 mediates desensitization of the oxytocin receptor (OXTR): GRK6-deficient mice display enhanced uterine contractility and high rates of term stillbirth; β-arrestin recruitment to OXTR (required for homologous desensitization) is dependent on GRK6 as shown in a heterologous cell model.","method":"GRK6-knockout mice, telemetry measurement of uterine contractility, β-arrestin recruitment assay in heterologous cell model, comparison with GRK5-KO","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice with in vivo functional readout, cellular β-arrestin recruitment assay, GRK5-KO control comparison","pmids":["26886170"],"is_preprint":false},{"year":2017,"finding":"GRK6 mediates signal termination of CCR7 and is essential for haptotactic (immobilized gradient) but not chemotactic (soluble gradient) CCL21-guided migration of dendritic cells; GRK6 deficiency impairs directionality along stable tissue-bound CCL21 gradients in vitro and in vivo.","method":"GRK6-knockout mice, controlled immobilized gradient assay, live-cell tracking, in vivo migration assay","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice, quantitative gradient assay distinguishing haptotaxis vs. chemotaxis, in vitro and in vivo validation","pmids":["28457871"],"is_preprint":false},{"year":2018,"finding":"GRK6 regulates chemerin-activated CMKLR1 in inflammatory macrophages: arrestin recruitment to CMKLR1 is enhanced by GRK6 co-expression; internalization of endogenous CMKLR1 is decreased in GRK6- and β-arrestin 2-deficient macrophages; GRK6/β-arrestin 2 deficiency increases macrophage migration toward chemerin and alters AKT and ERK signaling.","method":"GRK6-knockout mice, macrophage CMKLR1 internalization assay, β-arrestin recruitment assay, migration assay, AKT/ERK signaling measurement","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO model with receptor trafficking and signaling readouts, single lab","pmids":["30576947"],"is_preprint":false},{"year":2019,"finding":"The COMMD3/8 protein complex acts as an adaptor that selectively recruits GRK6 to activated chemoattractant receptors (including CXCR4), enabling GRK6-mediated receptor phosphorylation and β-arrestin-mediated signaling; COMMD8 stability depends on COMMD3; deficiency of COMMD8 or COMMD3 impairs B cell migration and humoral immunity.","method":"Co-immunoprecipitation (COMMD3/8-GRK6 complex), receptor phosphorylation assay, COMMD8/COMMD3-knockout mice, B cell migration assay, humoral immune response assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP identifying the complex, KO mice with multiple functional readouts, mechanistic ordering of complex components","pmids":["31088898"],"is_preprint":false},{"year":2020,"finding":"GRK6 regulates platelet hemostatic responses through agonist-selective GPCR desensitization: GRK6-knockout platelets show increased activation (Ca2+ mobilization, Akt activation, granule secretion) in response to PAR4 agonist and ADP but not TxA2; thrombin stimulation of human platelets increases GRK6 binding to PAR1 and PAR1 phosphorylation; GRK6 deletion in MEG-01 cells decreases PAR1 phosphorylation; GRK6-KO mice form larger thrombi.","method":"CRISPR-Cas9 GRK6-KO mice, platelet aggregation/secretion/Ca2+ assays, co-immunoprecipitation (GRK6-PAR1), Western blot for Akt/PAR1 phosphorylation, in vivo thrombosis model","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO, direct receptor co-IP, multiple signaling and in vivo functional readouts, single lab but orthogonal methods","pmids":["31899801"],"is_preprint":false},{"year":2022,"finding":"GRK6 regulates insulin processing and secretion in pancreatic β-cells: GRK6 knockdown in MIN6 cells reduces proprotein convertase expression and activity, impairing proinsulin-to-insulin conversion and reducing cellular insulin while enhancing proinsulin secretion; GRK6 rescue restores glucose-stimulated insulin secretion. The T2D-associated mutant GRK6-P384S is more catalytically active than WT GRK6 but displays cytosolic rather than plasma membrane localization and fails to enhance proinsulin processing.","method":"siRNA knockdown, pharmacological inhibition, GRK6 overexpression/rescue in MIN6 cells, proprotein convertase activity assay, insulin/proinsulin ELISA, subcellular localization imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and pharmacological interventions, biochemical enzyme activity assay, functional rescue, mutant characterization with localization data; single lab but multiple orthogonal methods","pmids":["36030052"],"is_preprint":false},{"year":2024,"finding":"Palmitoylation of GRK6 is required for its activation of the β-Arrestin 2/MAPKs/NF-κB signaling axis and for promoting metastasis in triple-negative breast cancer cells; kinase activity inhibition suppresses β-Arrestin 2 activation and cell migration.","method":"GRK6 knockdown/overexpression, palmitoylation-deficient mutant, Western blot for MAPK/NF-κB signaling, in vitro migration assay, in vivo lung colony-forming assay, pharmacological GRK6 inhibition","journal":"Breast cancer research : BCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays with mutagenesis and pharmacological inhibition, single lab","pmids":["39741338"],"is_preprint":false},{"year":2023,"finding":"LPS-induced palmitoylation of GRK6 increases its membrane translocation in Kupffer cells; palmitoylation-dependent membrane localization is required for GRK6 to activate the PI3K/AKT inflammatory signaling pathway; inhibiting GRK6 palmitoylation reduces membrane translocation and attenuates inflammatory response.","method":"Palmitoylation assay (Acyl-RAC), membrane/cytoplasmic protein fractionation, immunofluorescence, siRNA knockdown and overexpression, PI3K/AKT signaling readouts","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical detection of palmitoylation, fractionation showing localization shift, pathway inhibition readouts, single lab","pmids":["37012861"],"is_preprint":false},{"year":2024,"finding":"GRK6 depletion in lung adenocarcinoma cells induces HIF1α levels and activity, an effect mechanistically linked to regulation of VHL levels by GRK6.","method":"RNAi knockdown, RNA-seq, Western blot for HIF1α, VHL expression analysis, tissue microarray validation","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — knockdown with Western blot readout for VHL-HIF axis, no direct biochemical mechanism established, single lab","pmids":["34136390"],"is_preprint":false},{"year":2013,"finding":"GRK6 interacts with CXCR2 in dorsal root ganglion neurons as demonstrated by co-immunoprecipitation and immunofluorescence colocalization; GRK6 overexpression suppresses enhanced CXCR2 expression in DRG of CCI rats and attenuates neuropathic pain.","method":"Co-immunoprecipitation (GRK6-CXCR2), immunofluorescence, lentiviral GRK6 overexpression, behavioral pain assays","journal":"Molecular pain","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP with functional behavioral readout, no direct phosphorylation assay, single lab","pmids":["27145805"],"is_preprint":false}],"current_model":"GRK6 is a palmitoylated, membrane-associated serine/threonine kinase that phosphorylates agonist-activated GPCRs (including dopamine receptors, CXCR4, PAR1/PAR4, OXTR, CCR7, FFA4, secretin receptor) to promote β-arrestin recruitment, receptor desensitization, and internalization; its membrane targeting and catalytic activity are both enhanced by palmitoylation of C-terminal cysteines; it is selectively recruited to activated chemoattractant receptors via the COMMD3/8 adaptor complex; it also phosphorylates non-GPCR substrates including IκBα (promoting NF-κB signaling) and regulates Rac1 activation through GIT1 to promote apoptotic cell engulfment; structurally, the kinase and RGS-homology domains form an intimately associated catalytic core that adopts an open conformation in the absence of activated receptor, suggesting GPCR-induced domain closure as the activation mechanism."},"narrative":{"mechanistic_narrative":"GRK6 is a palmitoylated serine/threonine kinase of the GRK family that phosphorylates agonist-activated G protein-coupled receptors to drive their desensitization, β-arrestin recruitment, and internalization across diverse physiological systems [PMID:8366096, PMID:8077221, PMID:26886170]. Its catalytic core comprises intimately associated kinase and RGS-homology domains that adopt an open, inactive conformation in the absence of an activated receptor, implying that GPCR engagement triggers kinase-domain closure as the activation step [PMID:16613860]. Membrane targeting and intrinsic catalytic output are both governed by thioester palmitoylation of a C-terminal cysteine cluster (Cys561/562/565): palmitoylation is required for membrane partitioning and elevates kinase activity ~10-fold even toward soluble substrates, while a palmitoylation-deficient mutant has impaired receptor affinity and turnover [PMID:7961702, PMID:9341194, PMID:9819198]. Through this activity GRK6 terminates signaling at a broad receptor repertoire—CXCR4, CCR7, CMKLR1, the secretin receptor, FFA4/GPR120, the oxytocin receptor, and the platelet thrombin receptors PAR1/PAR4—with physiological consequences including lymphocyte and neutrophil chemotaxis, dendritic-cell haptotaxis, uterine contractility, and hemostasis [PMID:12032308, PMID:12598420, PMID:14704365, PMID:24412271, PMID:26886170, PMID:28457871, PMID:30576947, PMID:31899801]. Recruitment to activated chemoattractant receptors is selective, requiring an intact CXCR4 C-terminus and the COMMD3/8 adaptor complex [PMID:19956569, PMID:31088898]. Beyond canonical GPCR signaling, GRK6 phosphorylates IκBα at Ser32/Ser36 to promote NF-κB-driven inflammatory transcription and cooperates with GIT1 to activate Rac1 for apoptotic-cell engulfment; loss of GRK6 in mice causes autoimmune disease and impaired clearance of senescent red blood cells [PMID:23443560, PMID:25881508]. A T2D-associated GRK6-P384S variant is hyperactive yet mislocalized to the cytosol and fails to support β-cell proinsulin processing, linking GRK6 localization to insulin secretion [PMID:36030052].","teleology":[{"year":1993,"claim":"Established GRK6 as a distinct GRK-family kinase that phosphorylates agonist-activated GPCRs, defining its core biochemical identity.","evidence":"cDNA cloning and in vitro receptor phosphorylation of β2AR and rhodopsin with baculovirus-expressed enzyme","pmids":["8366096"],"confidence":"High","gaps":["Physiological receptor substrates not yet defined","No structural or regulatory mechanism"]},{"year":1994,"claim":"Identified C-terminal cysteine palmitoylation as the membrane-anchoring determinant, answering how a soluble kinase reaches its membrane receptor substrates.","evidence":"Metabolic [3H]palmitate labeling, hydroxylamine sensitivity, Cys mutagenesis, and subcellular fractionation; parallel purified-enzyme substrate assays","pmids":["7961702","8077221"],"confidence":"High","gaps":["Palmitoyltransferase responsible not identified","Whether palmitoylation is dynamic/regulated unknown"]},{"year":1997,"claim":"Showed palmitoylation is functionally required for receptor phosphorylation and sequestration, linking lipid modification to enzymatic competence in cells.","evidence":"Cys→Ser and CAAX-geranylgeranylated mutants tested in vesicle binding, kinase assays, and β2AR sequestration in COS-1 cells; splice variant characterization","pmids":["9341194","9316417"],"confidence":"High","gaps":["Distinct functions of GRK6a vs GRK6b isoforms not resolved"]},{"year":1998,"claim":"Demonstrated palmitoylation enhances intrinsic catalytic activity beyond mere membrane localization, revealing a second layer of regulation.","evidence":"Separation of palmitoylated vs non-palmitoylated fractions, soluble casein substrate assays, chemical depalmitoylation, geranylgeranylation rescue","pmids":["9819198"],"confidence":"High","gaps":["Structural basis for activity enhancement unknown"]},{"year":1999,"claim":"Mapped in vivo autophosphorylation sites (Ser484/Thr485), addressing how GRK6 regulates its own activity state.","evidence":"K215R catalytic-dead and phosphomimetic mutants with SDS-PAGE mobility shift and phosphatase treatment in COS-7 cells","pmids":["10334944"],"confidence":"Medium","gaps":["Functional consequence of autophosphorylation not established","Single lab, indirect mobility-shift readout"]},{"year":2002,"claim":"Revealed an unexpected positive role for GRK6 in chemotaxis despite its desensitizing function, complicating the simple receptor-shutoff model.","evidence":"GRK6-knockout mice with membrane GTPase, transwell, and transendothelial migration assays alongside βarrestin2- and GRK5-KO controls","pmids":["12032308"],"confidence":"High","gaps":["Mechanism reconciling impaired desensitization with impaired migration unresolved"]},{"year":2003,"claim":"Extended GRK6 substrate range to the secretin receptor with selectivity over other GPCRs, demonstrating receptor-specific desensitization.","evidence":"WT and dominant-negative GRK6 overexpression in NG108-15 cells with cAMP accumulation readout","pmids":["12598420"],"confidence":"Medium","gaps":["Direct receptor phosphorylation not shown","Single lab overexpression system"]},{"year":2004,"claim":"Placed GRK6 as the desensitizer of CXCR4 in neutrophils, connecting it to in vivo neutrophil mobilization and bone marrow retention.","evidence":"GRK6-KO neutrophils in calcium flux and chemotaxis assays plus in vivo G-CSF mobilization","pmids":["14704365"],"confidence":"High","gaps":["Direct CXCR4 phosphorylation sites not mapped here"]},{"year":2006,"claim":"Provided the structural model: an intimately associated kinase/RGS-H core in an open conformation, proposing GPCR-induced domain closure as the activation mechanism.","evidence":"2.6 Å X-ray crystal structure with comparison to GRK2 and dimerization functional assays","pmids":["16613860"],"confidence":"High","gaps":["Receptor-bound/activated conformation not captured","Direct demonstration of domain closure upon GPCR binding lacking"]},{"year":2009,"claim":"Explained receptor-side specificity of recruitment by showing GRK6 requires the CXCR4 C-terminus, and linked this to disease (WHIM syndrome) and chaperone-dependent stability in myeloma.","evidence":"Reciprocal co-IP of GRK6/GRK3 with WT vs WHIM-mutant CXCR4 plus β-arrestin/internalization/ERK readouts; GRK6-HSP90 co-IP and siRNA in myeloma","pmids":["19956569","19996089"],"confidence":"Medium","gaps":["Structural basis of C-terminal recognition unknown","Single-lab co-IP for each interaction"]},{"year":2013,"claim":"Uncovered a non-GPCR-desensitization function: GRK6-GIT1-Rac1 signaling drives apoptotic-cell engulfment, with loss causing autoimmunity and defective RBC clearance.","evidence":"GRK6-KO mice, engulfment and Rac1 activation assays, GRK6-GIT1 co-IP, mass spectrometry, autoimmune phenotyping","pmids":["23443560"],"confidence":"High","gaps":["Whether GRK6 kinase activity is required for GIT1/Rac1 effect not fully resolved"]},{"year":2013,"claim":"Linked GRK6 to CXCR2 regulation in sensory neurons and neuropathic pain, extending its receptor partners to a pain context.","evidence":"GRK6-CXCR2 co-IP, immunofluorescence colocalization, lentiviral overexpression with behavioral pain assays in CCI rats","pmids":["27145805"],"confidence":"Low","gaps":["No direct CXCR2 phosphorylation assay","Single co-IP with behavioral readout only"]},{"year":2014,"claim":"Defined GRK6 phosphorylation sites on FFA4/GPR120 controlling the balance between β-arrestin recruitment and Gαq/11 calcium signaling.","evidence":"GRK6 over/knockdown in HEK293, phosphosite mutagenesis, β-arrestin-2 recruitment and calcium assays","pmids":["24412271"],"confidence":"Medium","gaps":["In vivo relevance not tested","Single lab"]},{"year":2015,"claim":"Established a direct non-GPCR substrate, IκBα, placing GRK6 as a positive driver of NF-κB inflammatory transcription downstream of TNF-α.","evidence":"In vitro kinase assay on IκBα Ser32/36, kinase-dead mutant, BRET conformational sensor, GRK6-KO macrophages with inflammatory gene readouts","pmids":["25881508"],"confidence":"High","gaps":["How TNF-α routes signal to GRK6 conformational change unknown"]},{"year":2016,"claim":"Expanded the in vivo physiological roster (oxytocin receptor desensitization and hematopoietic stem cell maintenance), reinforcing GRK6 as a broad GPCR/kinase regulator.","evidence":"GRK6-KO mice with uterine telemetry and β-arrestin/OXTR assays; GRK6-DNA-PKcs co-IP, KO HSC phenotyping with α-lipoic acid rescue","pmids":["26886170","27882944"],"confidence":"Medium","gaps":["Whether DNA-PKcs is a direct GRK6 substrate not established","ROS link to HSC defect indirect"]},{"year":2017,"claim":"Distinguished GRK6's role in haptotaxis vs chemotaxis, showing it is essential for directional migration along immobilized CCL21-CCR7 gradients.","evidence":"GRK6-KO mice, controlled immobilized gradient assays, live-cell tracking, in vivo migration","pmids":["28457871"],"confidence":"High","gaps":["Molecular basis for haptotaxis specificity unclear"]},{"year":2019,"claim":"Identified the COMMD3/8 adaptor complex as the determinant of selective GRK6 recruitment to activated chemoattractant receptors, answering how GRK6 is targeted.","evidence":"COMMD3/8-GRK6 co-IP, receptor phosphorylation assay, COMMD8/COMMD3-KO mice, B cell migration and humoral immunity readouts","pmids":["31088898"],"confidence":"High","gaps":["Structural architecture of the COMMD3/8-GRK6-receptor assembly unknown"]},{"year":2020,"claim":"Demonstrated agonist-selective desensitization of platelet PAR1/PAR4 by GRK6, establishing a hemostatic function and direct receptor binding.","evidence":"CRISPR GRK6-KO mice/platelets, GRK6-PAR1 co-IP, PAR1 phosphorylation, signaling and in vivo thrombosis assays","pmids":["31899801"],"confidence":"High","gaps":["Why TxA2 receptor escapes GRK6 regulation unexplained"]},{"year":2023,"claim":"Connected palmitoylation-driven membrane translocation to inflammatory PI3K/AKT signaling, generalizing the lipid-modification regulatory theme to innate immunity.","evidence":"Acyl-RAC palmitoylation assay, fractionation, immunofluorescence, knockdown/overexpression with PI3K/AKT readouts in Kupffer cells","pmids":["37012861"],"confidence":"Medium","gaps":["Direct GRK6 substrate in PI3K/AKT pathway not identified","Single lab"]},{"year":2022,"claim":"Linked GRK6 localization to insulin processing and a T2D-associated variant, showing mislocalized hyperactive GRK6-P384S fails to support proinsulin conversion.","evidence":"siRNA/inhibitor/rescue in MIN6 cells, proprotein convertase activity, insulin/proinsulin ELISA, mutant localization imaging","pmids":["36030052"],"confidence":"High","gaps":["How GRK6 regulates proprotein convertase expression mechanistically unknown"]},{"year":2024,"claim":"Implicated palmitoylation-dependent GRK6 in cancer signaling and metastasis through the β-arrestin2/MAPK/NF-κB axis, and in HIF1α/VHL regulation.","evidence":"Palmitoylation-deficient mutant, knockdown/overexpression, migration and in vivo lung colonization assays, pharmacological inhibition (breast cancer); RNAi with HIF1α/VHL readouts (lung adenocarcinoma)","pmids":["39741338","34136390"],"confidence":"Medium","gaps":["Direct substrate driving metastatic signaling not defined","VHL-HIF1α link lacks direct biochemical mechanism"]},{"year":null,"claim":"How activated GPCRs convert the open kinase/RGS-H conformation into a closed, catalytically competent state remains structurally undefined, as does the integration of palmitoylation, COMMD3/8 recruitment, and conformational activation into a unified activation cycle.","evidence":"","pmids":[],"confidence":"High","gaps":["No receptor-bound GRK6 structure","Activation-cycle ordering of lipid modification, adaptor recruitment, and domain closure unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,15,16,22]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,5,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8,18,20,21]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,3,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,23,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,23]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,11,18,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,9,14,16,19,21]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[3,11,20]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[22]}],"complexes":["COMMD3/8 adaptor complex"],"partners":["CXCR4","PAR1","GIT1","COMMD3","COMMD8","HSP90","DNA-PKCS","CXCR2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P43250","full_name":"G protein-coupled receptor kinase 6","aliases":["G protein-coupled receptor kinase GRK6"],"length_aa":576,"mass_kda":66.0,"function":"Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamine receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/P43250/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRK6","classification":"Not Classified","n_dependent_lines":19,"n_total_lines":1208,"dependency_fraction":0.015728476821192054},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRK6","total_profiled":1310},"omim":[{"mim_id":"600870","title":"G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5","url":"https://www.omim.org/entry/600870"},{"mim_id":"600869","title":"G PROTEIN-COUPLED RECEPTOR KINASE 6; GRK6","url":"https://www.omim.org/entry/600869"},{"mim_id":"107941","title":"ARRESTIN, BETA, 2; ARRB2","url":"https://www.omim.org/entry/107941"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":126.6}],"url":"https://www.proteinatlas.org/search/GRK6"},"hgnc":{"alias_symbol":[],"prev_symbol":["GPRK6"]},"alphafold":{"accession":"P43250","domains":[{"cath_id":"1.10.167.10","chopping":"40-178","consensus_level":"medium","plddt":94.4576,"start":40,"end":178},{"cath_id":"3.30.200.20","chopping":"179-268_480-519","consensus_level":"medium","plddt":93.1388,"start":179,"end":519},{"cath_id":"1.10.510.10","chopping":"270-458","consensus_level":"high","plddt":95.691,"start":270,"end":458}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43250","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43250-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43250-F1-predicted_aligned_error_v6.png","plddt_mean":89.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRK6","jax_strain_url":"https://www.jax.org/strain/search?query=GRK6"},"sequence":{"accession":"P43250","fasta_url":"https://rest.uniprot.org/uniprotkb/P43250.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43250/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43250"}},"corpus_meta":[{"pmid":"12032308","id":"PMC_12032308","title":"Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12032308","citation_count":255,"is_preprint":false},{"pmid":"8366096","id":"PMC_8366096","title":"Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8366096","citation_count":117,"is_preprint":false},{"pmid":"20410529","id":"PMC_20410529","title":"Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.","date":"2010","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20410529","citation_count":111,"is_preprint":false},{"pmid":"7961702","id":"PMC_7961702","title":"Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7961702","citation_count":108,"is_preprint":false},{"pmid":"19996089","id":"PMC_19996089","title":"Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19996089","citation_count":94,"is_preprint":false},{"pmid":"15686961","id":"PMC_15686961","title":"L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15686961","citation_count":79,"is_preprint":false},{"pmid":"16613860","id":"PMC_16613860","title":"The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16613860","citation_count":78,"is_preprint":false},{"pmid":"14704365","id":"PMC_14704365","title":"GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/14704365","citation_count":77,"is_preprint":false},{"pmid":"8077221","id":"PMC_8077221","title":"Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8077221","citation_count":69,"is_preprint":false},{"pmid":"8977246","id":"PMC_8977246","title":"Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8977246","citation_count":65,"is_preprint":false},{"pmid":"19956569","id":"PMC_19956569","title":"Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956569","citation_count":57,"is_preprint":false},{"pmid":"24412271","id":"PMC_24412271","title":"Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.","date":"2014","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24412271","citation_count":53,"is_preprint":false},{"pmid":"28457871","id":"PMC_28457871","title":"Dendritic Cells Interpret Haptotactic Chemokine Gradients in a Manner Governed by Signal-to-Noise Ratio and Dependent on GRK6.","date":"2017","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/28457871","citation_count":50,"is_preprint":false},{"pmid":"9819198","id":"PMC_9819198","title":"Palmitoylation increases the kinase activity of the G protein-coupled receptor kinase, GRK6.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9819198","citation_count":45,"is_preprint":false},{"pmid":"9495886","id":"PMC_9495886","title":"Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6.","date":"1998","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/9495886","citation_count":44,"is_preprint":false},{"pmid":"23443560","id":"PMC_23443560","title":"GRK6 deficiency in mice causes autoimmune disease due to impaired apoptotic cell clearance.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23443560","citation_count":42,"is_preprint":false},{"pmid":"9341194","id":"PMC_9341194","title":"Altered activity of palmitoylation-deficient and isoprenylated forms of the G protein-coupled receptor kinase GRK6.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9341194","citation_count":38,"is_preprint":false},{"pmid":"31088898","id":"PMC_31088898","title":"The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31088898","citation_count":36,"is_preprint":false},{"pmid":"31227976","id":"PMC_31227976","title":"MiR-19b-3p attenuates IL-1β induced extracellular matrix degradation and inflammatory injury in chondrocytes by targeting GRK6.","date":"2019","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31227976","citation_count":36,"is_preprint":false},{"pmid":"20799926","id":"PMC_20799926","title":"Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20799926","citation_count":36,"is_preprint":false},{"pmid":"23497290","id":"PMC_23497290","title":"Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.","date":"2013","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23497290","citation_count":33,"is_preprint":false},{"pmid":"28106155","id":"PMC_28106155","title":"Secreted miR-27a Induced by Cyclic Stretch Modulates the Proliferation of Endothelial Cells in Hypertension via GRK6.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28106155","citation_count":31,"is_preprint":false},{"pmid":"9316417","id":"PMC_9316417","title":"Molecular cloning of two rat GRK6 splice variants.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9316417","citation_count":27,"is_preprint":false},{"pmid":"27145805","id":"PMC_27145805","title":"Overexpression of GRK6 attenuates neuropathic pain via suppression of CXCR2 in rat dorsal root ganglion.","date":"2016","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/27145805","citation_count":25,"is_preprint":false},{"pmid":"30576947","id":"PMC_30576947","title":"Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages.","date":"2018","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30576947","citation_count":25,"is_preprint":false},{"pmid":"27882944","id":"PMC_27882944","title":"GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27882944","citation_count":23,"is_preprint":false},{"pmid":"31899801","id":"PMC_31899801","title":"GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31899801","citation_count":23,"is_preprint":false},{"pmid":"22393477","id":"PMC_22393477","title":"The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.","date":"2012","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/22393477","citation_count":23,"is_preprint":false},{"pmid":"25687550","id":"PMC_25687550","title":"Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.","date":"2015","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25687550","citation_count":22,"is_preprint":false},{"pmid":"25881508","id":"PMC_25881508","title":"GRK6 phosphorylates IκBα at Ser(32)/Ser(36) and enhances TNF-α-induced inflammation.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25881508","citation_count":20,"is_preprint":false},{"pmid":"34291633","id":"PMC_34291633","title":"Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34291633","citation_count":18,"is_preprint":false},{"pmid":"23375037","id":"PMC_23375037","title":"GRK6 expression in patients with hepatocellular carcinoma.","date":"2013","source":"Asian Pacific journal of tropical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23375037","citation_count":17,"is_preprint":false},{"pmid":"32486261","id":"PMC_32486261","title":"Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32486261","citation_count":15,"is_preprint":false},{"pmid":"7789183","id":"PMC_7789183","title":"Chromosomal mapping of the genes GPRK5 and GPRK6 encoding G protein-coupled receptor kinases GRK5 and GRK6.","date":"1995","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7789183","citation_count":14,"is_preprint":false},{"pmid":"10334944","id":"PMC_10334944","title":"Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10334944","citation_count":12,"is_preprint":false},{"pmid":"26886170","id":"PMC_26886170","title":"Enhanced Uterine Contractility and Stillbirth in Mice Lacking G Protein-Coupled Receptor Kinase 6 (GRK6): Implications for Oxytocin Receptor Desensitization.","date":"2016","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/26886170","citation_count":12,"is_preprint":false},{"pmid":"28526450","id":"PMC_28526450","title":"The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes.","date":"2017","source":"American journal of obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/28526450","citation_count":12,"is_preprint":false},{"pmid":"30984536","id":"PMC_30984536","title":"Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.","date":"2019","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/30984536","citation_count":10,"is_preprint":false},{"pmid":"12598420","id":"PMC_12598420","title":"G protein-coupled receptor kinase 6 (GRK6) selectively regulates endogenous secretin receptor responsiveness in NG108-15 cells.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12598420","citation_count":10,"is_preprint":false},{"pmid":"9387888","id":"PMC_9387888","title":"Molecular cloning of rat G-protein-coupled receptor kinase 6 (GRK6) from brain tissue, and its mRNA expression in different brain regions and peripheral tissues.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9387888","citation_count":10,"is_preprint":false},{"pmid":"25316534","id":"PMC_25316534","title":"Functional consequences of perturbed CXCL12 signal processing: analyses of immature hematopoiesis in GRK6-deficient mice.","date":"2014","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/25316534","citation_count":10,"is_preprint":false},{"pmid":"36261031","id":"PMC_36261031","title":"M2 macrophages-derived exosomal miR-3917 promotes the progression of lung cancer via targeting GRK6.","date":"2022","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36261031","citation_count":9,"is_preprint":false},{"pmid":"32484026","id":"PMC_32484026","title":"Downregulation of GRK6 in arcuate nucleus promotes chronic visceral hypersensitivity via NF-κB upregulation in adult rats with neonatal maternal deprivation.","date":"2020","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/32484026","citation_count":9,"is_preprint":false},{"pmid":"23359120","id":"PMC_23359120","title":"Expression of G-protein-coupled receptor kinase 6 (GRK6) after acute spinal cord injury in adult rat.","date":"2013","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/23359120","citation_count":9,"is_preprint":false},{"pmid":"35349212","id":"PMC_35349212","title":"Overexpression of GRK6 alleviates chronic visceral hypersensitivity through downregulation of P2Y6 receptors in anterior cingulate cortex of rats with prenatal maternal stress.","date":"2022","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35349212","citation_count":9,"is_preprint":false},{"pmid":"37012861","id":"PMC_37012861","title":"GRK6 palmitoylation increasing its membrance translocation promotes LPS-induced inflammation by PI3K/ AKT pathway in kuppfer cells.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37012861","citation_count":8,"is_preprint":false},{"pmid":"23979726","id":"PMC_23979726","title":"Decreased expression and role of GRK6 in spinal cord of rats after chronic constriction injury.","date":"2013","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/23979726","citation_count":8,"is_preprint":false},{"pmid":"36030052","id":"PMC_36030052","title":"G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulin.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36030052","citation_count":7,"is_preprint":false},{"pmid":"37706561","id":"PMC_37706561","title":"miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population.","date":"2023","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/37706561","citation_count":7,"is_preprint":false},{"pmid":"9016947","id":"PMC_9016947","title":"Identification and chromosomal localization of a processed pseudogene of human GRK6.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9016947","citation_count":7,"is_preprint":false},{"pmid":"23583200","id":"PMC_23583200","title":"GRK-6 mediates FSH action synergistically enhanced by estrogen and the oocyte in rat granulosa cells.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23583200","citation_count":7,"is_preprint":false},{"pmid":"39741338","id":"PMC_39741338","title":"GRK6 palmitoylation dictates triple-negative breast cancer metastasis via recruiting the β-Arrestin 2/MAPKs/NF-κB signaling axis.","date":"2024","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/39741338","citation_count":5,"is_preprint":false},{"pmid":"37742818","id":"PMC_37742818","title":"Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.","date":"2023","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37742818","citation_count":4,"is_preprint":false},{"pmid":"34136390","id":"PMC_34136390","title":"GRK6 Depletion Induces HIF Activity in Lung Adenocarcinoma.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34136390","citation_count":3,"is_preprint":false},{"pmid":"29884229","id":"PMC_29884229","title":"Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract.","date":"2018","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/29884229","citation_count":3,"is_preprint":false},{"pmid":"39824142","id":"PMC_39824142","title":"Ligand-based cheminformatics and free energy-inspired molecular simulations for prioritizing and optimizing G-protein coupled receptor kinase-6 (GRK6) inhibitors in multiple myeloma treatment.","date":"2025","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39824142","citation_count":2,"is_preprint":false},{"pmid":"25723280","id":"PMC_25723280","title":"A novel monoclonal antibody against human GRK6 antigen.","date":"2015","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/25723280","citation_count":0,"is_preprint":false},{"pmid":"27784368","id":"PMC_27784368","title":"[Effect of GRK6 on Proliferation of Multiple Myeloma MM1R Cells and Its Mechanism].","date":"2016","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/27784368","citation_count":0,"is_preprint":false},{"pmid":"41278839","id":"PMC_41278839","title":"REST elevation-dependent chromatin remodeling and alternative Grk6 transcript synthesis hyperactivates Cxcr4-Sdf1 signaling in cerebellar granule cell progenitors.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41278839","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.21.649864","title":"Parallel CRISPR screens reveal pathways controlling the cell surface levels of the attractant receptor FPR1","date":"2025-04-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.21.649864","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.11.642421","title":"Rare variant in intracellular loop-2 of the ghrelin receptor reveals novel mechanisms of GPCR biased signaling and trafficking","date":"2025-03-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.11.642421","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34645,"output_tokens":7388,"usd":0.107378,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16619,"output_tokens":6002,"usd":0.116572,"stage2_stop_reason":"end_turn"},"total_usd":0.22395,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GRK6 was cloned as a 576-amino acid serine/threonine kinase that phosphorylates activated G protein-coupled receptors (β2-adrenergic receptor and rhodopsin) in a stimulus-dependent fashion, establishing it as a member of the GRK family with substrate specificity distinct from βARK and rhodopsin kinase.\",\n      \"method\": \"cDNA cloning, baculovirus overexpression in Sf9 cells, in vitro receptor phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation assay with purified protein, foundational cloning paper replicated by subsequent studies\",\n      \"pmids\": [\"8366096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"GRK6 is palmitoylated at a cluster of three C-terminal cysteines (Cys561, Cys562, Cys565) via a thioester bond, and this palmitoylation is essential for membrane association; palmitoylated GRK6 partitions exclusively to the membrane fraction.\",\n      \"method\": \"Metabolic labeling with [3H]palmitate, hydroxylamine treatment, HPLC, site-directed mutagenesis, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with mutagenesis, biochemical fractionation, and chemical verification of lipid linkage in single rigorous study\",\n      \"pmids\": [\"7961702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Purified GRK6 phosphorylates rhodopsin, β2-adrenergic receptor, and m2 muscarinic receptor in a stimulus-dependent manner; GRK6 shares inhibition by heparin/dextran sulfate and preference for non-acidic peptide substrates with GRK5, but has lower stoichiometry on these receptors than GRK5 or βARK and does not undergo significant autophosphorylation.\",\n      \"method\": \"Protein purification (SP-Sepharose/heparin-Sepharose), in vitro kinase assays with receptor substrates and peptides, inhibitor titration\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzyme, multiple orthogonal substrate assays, rigorous biochemical characterization\",\n      \"pmids\": [\"8077221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Palmitoylation of GRK6 is required for its membrane binding and activity toward receptor substrates: a palmitoylation-deficient mutant (Cys→Ser) shows ~5-fold higher Km and ~2-fold lower Vmax for rhodopsin and minimal β2-adrenergic receptor sequestration in COS-1 cells, while a geranylgeranylated GRK6 mutant (CAAX-tagged) shows enhanced membrane binding and ~14-fold higher Vmax.\",\n      \"method\": \"Site-directed mutagenesis, phospholipid vesicle binding assay, in vitro kinase assay, β2AR sequestration assay in COS-1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with multiple orthogonal functional assays, replicated across cell-free and cellular systems\",\n      \"pmids\": [\"9341194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Two GRK6 splice variants (GRK6a: 576 aa, GRK6b: 589 aa with a distinct C-terminal region due to a 2-bp intron insert) are expressed in rat tissues; GRK6a predominates in brain, GRK6b is more abundant in peripheral tissues; both isoforms phosphorylate light-activated rhodopsin and a synthetic peptide substrate.\",\n      \"method\": \"RT-PCR cloning, in vitro kinase assay with CHO cell cytosol extracts\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — functional assay confirmed for both isoforms but performed in crude cytosol extracts, single lab\",\n      \"pmids\": [\"9316417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Palmitoylation of GRK6 increases its kinase catalytic activity intrinsically (beyond membrane localization): palmitoylated GRK6 is 10-fold more active than non-palmitoylated GRK6 at phosphorylating β2AR, and this elevated activity is also observed with the soluble substrate casein. Chemical depalmitoylation reduces casein phosphorylation activity, indicating palmitoylation directly enhances catalytic activity.\",\n      \"method\": \"Separation of palmitoylated vs. non-palmitoylated GRK6 fractions, in vitro kinase assays (β2AR and casein substrates), chemical depalmitoylation, geranylgeranylation rescue\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal substrate assays, chemical manipulation of palmitoylation state, single lab\",\n      \"pmids\": [\"9819198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GRK6 autophosphorylates on Ser484 and Thr485 in vivo (in COS-7 cells), as revealed by electrophoretic mobility shift: catalytically inactive GRK6-K215R runs at 63 kDa (hypophosphorylated), while GRK6-K215R with S484D/T485D phosphomimetic mutations (GRK6-RDD) restores the 66 kDa mobility of wild-type GRK6. The C5a receptor (C5aR) is not a substrate for GRK6 in this system.\",\n      \"method\": \"Site-directed mutagenesis, SDS-PAGE mobility shift analysis, phosphatase treatment, overexpression in COS-7 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with electrophoretic evidence of autophosphorylation sites, two orthogonal approaches (mobility shift + phosphatase), single lab\",\n      \"pmids\": [\"10334944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GRK6 plays a positive regulatory role in CXCL12 (SDF-1)-stimulated chemotaxis of T and B lymphocytes: GRK6-knockout mice show increased CXCL12-stimulated membrane GTPase activity (indicating impaired receptor desensitization) yet paradoxically impaired chemotaxis of T cells in transwell and transendothelial migration assays.\",\n      \"method\": \"GRK6-knockout mice, membrane GTPase activity assay, transwell migration assay, transendothelial migration assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mice, multiple orthogonal functional assays, parallel comparison with βarrestin2-KO and GRK5-KO controls\",\n      \"pmids\": [\"12032308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRK6 selectively desensitizes the secretin receptor in NG108-15 cells: overexpression of wild-type GRK6 reduces secretin-stimulated cAMP accumulation while dominant-negative GRK6 (K215R) enhances it, without affecting adenosine A2 or prostanoid IP receptor responses.\",\n      \"method\": \"Transient overexpression of WT and dominant-negative GRK6 in NG108-15 cells, cAMP accumulation assay\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative and wild-type overexpression with selective receptor specificity established, single lab\",\n      \"pmids\": [\"12598420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GRK6 mediates desensitization of CXCR4 in neutrophils: GRK6-deficient neutrophils show enhanced SDF-1-induced chemotaxis in vitro and impaired desensitization of calcium responses to SDF-1; in vivo, GRK6-deficient mice have profoundly impaired G-CSF-induced neutrophil mobilization from bone marrow, attributed to enhanced CXCR4-mediated bone marrow retention.\",\n      \"method\": \"GRK6-knockout mice, in vitro chemotaxis assay (transwell), calcium flux assay, in vivo G-CSF treatment with blood neutrophil counting\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout model with multiple functional readouts (calcium, migration, in vivo mobilization) and mechanistic pathway placement\",\n      \"pmids\": [\"14704365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure of human GRK6 at 2.6 Å resolution reveals: (1) the catalytic core consists of intimately associated kinase and RGS homology (RGS-H) domains; (2) despite ATP analog binding, the kinase domain is in an open/inactive conformation, suggesting GPCRs activate GRKs by inducing kinase domain closure; (3) a putative phospholipid-binding site near the N-terminus; (4) structural elements in the substrate channel that influence GPCR access and specificity; (5) the RGS-H domain forms a dimer interface in the crystal using conserved hydrophobic residues, but dimerization is not required for receptor phosphorylation.\",\n      \"method\": \"X-ray crystallography (2.6 Å), structural comparison with GRK2, functional assays for dimerization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation of dimerization dispensability, defines second lineage of GRKs\",\n      \"pmids\": [\"16613860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GRK6 fails to associate with WHIM-syndrome-associated mutant CXCR4 (lacking the C-terminal 19 residues) after ligand activation, while GRK3 associates normally; this impaired GRK6 recruitment correlates with delayed β-arrestin 2 recruitment, slower receptor internalization, and slower ERK1/2 activation, providing a molecular mechanism for CXCR4 dysfunction in WHIM syndrome.\",\n      \"method\": \"Co-immunoprecipitation of GRK6 and GRK3 with WT vs. WHIM-mutant CXCR4, β-arrestin recruitment assay, internalization assay, ERK activation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with two GRKs, correlated with functional downstream readouts, single lab\",\n      \"pmids\": [\"19956569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GRK6 expression in multiple myeloma cells is stabilized by direct association with the HSP90 chaperone; GRK6 silencing suppresses STAT3 phosphorylation and reduces MCL1 levels and phosphorylation, causing selective lethality in myeloma cells.\",\n      \"method\": \"Co-immunoprecipitation (GRK6-HSP90 interaction), siRNA knockdown, Western blot for STAT3 phosphorylation and MCL1, cell viability assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for interaction, functional knockdown with defined signaling readouts, single lab\",\n      \"pmids\": [\"19996089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GRK6 is recruited to the lyso-PC-activated G2A receptor in neutrophils (PMNs) as demonstrated by co-immunoprecipitation and digital microscopy, contributing to receptor desensitization as part of a signaling complex that also includes clathrin and β-arrestin-1.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, subcellular fractionation, FRET-based digital microscopy\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and FRET evidence of recruitment, multiple imaging methods, single lab\",\n      \"pmids\": [\"20799926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRK6 promotes apoptotic cell clearance by cooperating with GIT1 to activate Rac1, enabling cytoskeletal rearrangement of phagocytes for engulfment; this pathway acts independently of the known DOCK180/ELMO/Rac1 and GULP1/Rac1 engulfment pathways. GRK6-deficient mice develop autoimmune disease and accumulate iron stores in splenic red pulp due to impaired senescent red blood cell clearance.\",\n      \"method\": \"GRK6-knockout mice, engulfment assays, co-immunoprecipitation (GRK6-GIT1), Rac1 activation assay, mass spectrometry, autoimmune phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mice with defined molecular mechanism (GRK6-GIT1-Rac1), epistasis with known pathways, multiple orthogonal functional readouts\",\n      \"pmids\": [\"23443560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRK6 mediates agonist-induced homologous phosphorylation of FFA4/GPR120 at Thr347, Ser350, and Ser357 in the C-terminal tail; concurrent mutation of these sites impairs β-arrestin-2 recruitment to the receptor membrane and enhances Gαq/11-mediated calcium responses.\",\n      \"method\": \"GRK6 overexpression/knockdown in HEK293 cells, phosphorylation site mutagenesis, β-arrestin-2 recruitment assay, calcium flux assay\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis of phosphorylation sites combined with functional signaling assays, single lab\",\n      \"pmids\": [\"24412271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRK6 directly phosphorylates IκBα at Ser32/Ser36 (the canonical NF-κB activation phosphorylation sites); GRK6 kinase activity is required for promoting NF-κB signaling after TNF-α stimulation; TNF-α induces a conformational change in GRK6 (monitored by BRET probe); GRK6 knockout in macrophages attenuates TNF-α-induced inflammatory gene transcription.\",\n      \"method\": \"In vitro kinase assay (GRK6 phosphorylating IκBα), kinase-dead mutant, BRET conformational sensor, GRK6-KO macrophages, inflammatory gene expression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation of IκBα, mutagenesis, BRET, and KO functional validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25881508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GRK6 interacts with and regulates phosphorylation of DNA-PKcs (DNA-dependent protein kinase, catalytic subunit); GRK6 knockout leads to impaired HSC self-renewal, lymphocytopenia, and loss of multiple hematopoietic progenitor populations, which are partially rescued by reactive oxygen species scavenger α-lipoic acid.\",\n      \"method\": \"GRK6-knockout mice, co-immunoprecipitation (GRK6-DNA-PKcs), Western blot for phosphorylation, transcriptome/proteomic analysis, α-lipoic acid rescue experiment\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for interaction, KO phenotype with pharmacological rescue, single lab\",\n      \"pmids\": [\"27882944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GRK6 mediates desensitization of the oxytocin receptor (OXTR): GRK6-deficient mice display enhanced uterine contractility and high rates of term stillbirth; β-arrestin recruitment to OXTR (required for homologous desensitization) is dependent on GRK6 as shown in a heterologous cell model.\",\n      \"method\": \"GRK6-knockout mice, telemetry measurement of uterine contractility, β-arrestin recruitment assay in heterologous cell model, comparison with GRK5-KO\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice with in vivo functional readout, cellular β-arrestin recruitment assay, GRK5-KO control comparison\",\n      \"pmids\": [\"26886170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GRK6 mediates signal termination of CCR7 and is essential for haptotactic (immobilized gradient) but not chemotactic (soluble gradient) CCL21-guided migration of dendritic cells; GRK6 deficiency impairs directionality along stable tissue-bound CCL21 gradients in vitro and in vivo.\",\n      \"method\": \"GRK6-knockout mice, controlled immobilized gradient assay, live-cell tracking, in vivo migration assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice, quantitative gradient assay distinguishing haptotaxis vs. chemotaxis, in vitro and in vivo validation\",\n      \"pmids\": [\"28457871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GRK6 regulates chemerin-activated CMKLR1 in inflammatory macrophages: arrestin recruitment to CMKLR1 is enhanced by GRK6 co-expression; internalization of endogenous CMKLR1 is decreased in GRK6- and β-arrestin 2-deficient macrophages; GRK6/β-arrestin 2 deficiency increases macrophage migration toward chemerin and alters AKT and ERK signaling.\",\n      \"method\": \"GRK6-knockout mice, macrophage CMKLR1 internalization assay, β-arrestin recruitment assay, migration assay, AKT/ERK signaling measurement\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO model with receptor trafficking and signaling readouts, single lab\",\n      \"pmids\": [\"30576947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The COMMD3/8 protein complex acts as an adaptor that selectively recruits GRK6 to activated chemoattractant receptors (including CXCR4), enabling GRK6-mediated receptor phosphorylation and β-arrestin-mediated signaling; COMMD8 stability depends on COMMD3; deficiency of COMMD8 or COMMD3 impairs B cell migration and humoral immunity.\",\n      \"method\": \"Co-immunoprecipitation (COMMD3/8-GRK6 complex), receptor phosphorylation assay, COMMD8/COMMD3-knockout mice, B cell migration assay, humoral immune response assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP identifying the complex, KO mice with multiple functional readouts, mechanistic ordering of complex components\",\n      \"pmids\": [\"31088898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK6 regulates platelet hemostatic responses through agonist-selective GPCR desensitization: GRK6-knockout platelets show increased activation (Ca2+ mobilization, Akt activation, granule secretion) in response to PAR4 agonist and ADP but not TxA2; thrombin stimulation of human platelets increases GRK6 binding to PAR1 and PAR1 phosphorylation; GRK6 deletion in MEG-01 cells decreases PAR1 phosphorylation; GRK6-KO mice form larger thrombi.\",\n      \"method\": \"CRISPR-Cas9 GRK6-KO mice, platelet aggregation/secretion/Ca2+ assays, co-immunoprecipitation (GRK6-PAR1), Western blot for Akt/PAR1 phosphorylation, in vivo thrombosis model\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO, direct receptor co-IP, multiple signaling and in vivo functional readouts, single lab but orthogonal methods\",\n      \"pmids\": [\"31899801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GRK6 regulates insulin processing and secretion in pancreatic β-cells: GRK6 knockdown in MIN6 cells reduces proprotein convertase expression and activity, impairing proinsulin-to-insulin conversion and reducing cellular insulin while enhancing proinsulin secretion; GRK6 rescue restores glucose-stimulated insulin secretion. The T2D-associated mutant GRK6-P384S is more catalytically active than WT GRK6 but displays cytosolic rather than plasma membrane localization and fails to enhance proinsulin processing.\",\n      \"method\": \"siRNA knockdown, pharmacological inhibition, GRK6 overexpression/rescue in MIN6 cells, proprotein convertase activity assay, insulin/proinsulin ELISA, subcellular localization imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and pharmacological interventions, biochemical enzyme activity assay, functional rescue, mutant characterization with localization data; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"36030052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Palmitoylation of GRK6 is required for its activation of the β-Arrestin 2/MAPKs/NF-κB signaling axis and for promoting metastasis in triple-negative breast cancer cells; kinase activity inhibition suppresses β-Arrestin 2 activation and cell migration.\",\n      \"method\": \"GRK6 knockdown/overexpression, palmitoylation-deficient mutant, Western blot for MAPK/NF-κB signaling, in vitro migration assay, in vivo lung colony-forming assay, pharmacological GRK6 inhibition\",\n      \"journal\": \"Breast cancer research : BCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays with mutagenesis and pharmacological inhibition, single lab\",\n      \"pmids\": [\"39741338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LPS-induced palmitoylation of GRK6 increases its membrane translocation in Kupffer cells; palmitoylation-dependent membrane localization is required for GRK6 to activate the PI3K/AKT inflammatory signaling pathway; inhibiting GRK6 palmitoylation reduces membrane translocation and attenuates inflammatory response.\",\n      \"method\": \"Palmitoylation assay (Acyl-RAC), membrane/cytoplasmic protein fractionation, immunofluorescence, siRNA knockdown and overexpression, PI3K/AKT signaling readouts\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical detection of palmitoylation, fractionation showing localization shift, pathway inhibition readouts, single lab\",\n      \"pmids\": [\"37012861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GRK6 depletion in lung adenocarcinoma cells induces HIF1α levels and activity, an effect mechanistically linked to regulation of VHL levels by GRK6.\",\n      \"method\": \"RNAi knockdown, RNA-seq, Western blot for HIF1α, VHL expression analysis, tissue microarray validation\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — knockdown with Western blot readout for VHL-HIF axis, no direct biochemical mechanism established, single lab\",\n      \"pmids\": [\"34136390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRK6 interacts with CXCR2 in dorsal root ganglion neurons as demonstrated by co-immunoprecipitation and immunofluorescence colocalization; GRK6 overexpression suppresses enhanced CXCR2 expression in DRG of CCI rats and attenuates neuropathic pain.\",\n      \"method\": \"Co-immunoprecipitation (GRK6-CXCR2), immunofluorescence, lentiviral GRK6 overexpression, behavioral pain assays\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP with functional behavioral readout, no direct phosphorylation assay, single lab\",\n      \"pmids\": [\"27145805\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRK6 is a palmitoylated, membrane-associated serine/threonine kinase that phosphorylates agonist-activated GPCRs (including dopamine receptors, CXCR4, PAR1/PAR4, OXTR, CCR7, FFA4, secretin receptor) to promote β-arrestin recruitment, receptor desensitization, and internalization; its membrane targeting and catalytic activity are both enhanced by palmitoylation of C-terminal cysteines; it is selectively recruited to activated chemoattractant receptors via the COMMD3/8 adaptor complex; it also phosphorylates non-GPCR substrates including IκBα (promoting NF-κB signaling) and regulates Rac1 activation through GIT1 to promote apoptotic cell engulfment; structurally, the kinase and RGS-homology domains form an intimately associated catalytic core that adopts an open conformation in the absence of activated receptor, suggesting GPCR-induced domain closure as the activation mechanism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRK6 is a palmitoylated serine/threonine kinase of the GRK family that phosphorylates agonist-activated G protein-coupled receptors to drive their desensitization, β-arrestin recruitment, and internalization across diverse physiological systems [#0, #2, #18]. Its catalytic core comprises intimately associated kinase and RGS-homology domains that adopt an open, inactive conformation in the absence of an activated receptor, implying that GPCR engagement triggers kinase-domain closure as the activation step [#10]. Membrane targeting and intrinsic catalytic output are both governed by thioester palmitoylation of a C-terminal cysteine cluster (Cys561/562/565): palmitoylation is required for membrane partitioning and elevates kinase activity ~10-fold even toward soluble substrates, while a palmitoylation-deficient mutant has impaired receptor affinity and turnover [#1, #3, #5]. Through this activity GRK6 terminates signaling at a broad receptor repertoire—CXCR4, CCR7, CMKLR1, the secretin receptor, FFA4/GPR120, the oxytocin receptor, and the platelet thrombin receptors PAR1/PAR4—with physiological consequences including lymphocyte and neutrophil chemotaxis, dendritic-cell haptotaxis, uterine contractility, and hemostasis [#7, #8, #9, #15, #18, #19, #20, #22]. Recruitment to activated chemoattractant receptors is selective, requiring an intact CXCR4 C-terminus and the COMMD3/8 adaptor complex [#11, #21]. Beyond canonical GPCR signaling, GRK6 phosphorylates IκBα at Ser32/Ser36 to promote NF-κB-driven inflammatory transcription and cooperates with GIT1 to activate Rac1 for apoptotic-cell engulfment; loss of GRK6 in mice causes autoimmune disease and impaired clearance of senescent red blood cells [#14, #16]. A T2D-associated GRK6-P384S variant is hyperactive yet mislocalized to the cytosol and fails to support β-cell proinsulin processing, linking GRK6 localization to insulin secretion [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established GRK6 as a distinct GRK-family kinase that phosphorylates agonist-activated GPCRs, defining its core biochemical identity.\",\n      \"evidence\": \"cDNA cloning and in vitro receptor phosphorylation of β2AR and rhodopsin with baculovirus-expressed enzyme\",\n      \"pmids\": [\"8366096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological receptor substrates not yet defined\", \"No structural or regulatory mechanism\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identified C-terminal cysteine palmitoylation as the membrane-anchoring determinant, answering how a soluble kinase reaches its membrane receptor substrates.\",\n      \"evidence\": \"Metabolic [3H]palmitate labeling, hydroxylamine sensitivity, Cys mutagenesis, and subcellular fractionation; parallel purified-enzyme substrate assays\",\n      \"pmids\": [\"7961702\", \"8077221\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Palmitoyltransferase responsible not identified\", \"Whether palmitoylation is dynamic/regulated unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed palmitoylation is functionally required for receptor phosphorylation and sequestration, linking lipid modification to enzymatic competence in cells.\",\n      \"evidence\": \"Cys→Ser and CAAX-geranylgeranylated mutants tested in vesicle binding, kinase assays, and β2AR sequestration in COS-1 cells; splice variant characterization\",\n      \"pmids\": [\"9341194\", \"9316417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct functions of GRK6a vs GRK6b isoforms not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated palmitoylation enhances intrinsic catalytic activity beyond mere membrane localization, revealing a second layer of regulation.\",\n      \"evidence\": \"Separation of palmitoylated vs non-palmitoylated fractions, soluble casein substrate assays, chemical depalmitoylation, geranylgeranylation rescue\",\n      \"pmids\": [\"9819198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for activity enhancement unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped in vivo autophosphorylation sites (Ser484/Thr485), addressing how GRK6 regulates its own activity state.\",\n      \"evidence\": \"K215R catalytic-dead and phosphomimetic mutants with SDS-PAGE mobility shift and phosphatase treatment in COS-7 cells\",\n      \"pmids\": [\"10334944\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of autophosphorylation not established\", \"Single lab, indirect mobility-shift readout\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed an unexpected positive role for GRK6 in chemotaxis despite its desensitizing function, complicating the simple receptor-shutoff model.\",\n      \"evidence\": \"GRK6-knockout mice with membrane GTPase, transwell, and transendothelial migration assays alongside βarrestin2- and GRK5-KO controls\",\n      \"pmids\": [\"12032308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism reconciling impaired desensitization with impaired migration unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended GRK6 substrate range to the secretin receptor with selectivity over other GPCRs, demonstrating receptor-specific desensitization.\",\n      \"evidence\": \"WT and dominant-negative GRK6 overexpression in NG108-15 cells with cAMP accumulation readout\",\n      \"pmids\": [\"12598420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor phosphorylation not shown\", \"Single lab overexpression system\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed GRK6 as the desensitizer of CXCR4 in neutrophils, connecting it to in vivo neutrophil mobilization and bone marrow retention.\",\n      \"evidence\": \"GRK6-KO neutrophils in calcium flux and chemotaxis assays plus in vivo G-CSF mobilization\",\n      \"pmids\": [\"14704365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct CXCR4 phosphorylation sites not mapped here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided the structural model: an intimately associated kinase/RGS-H core in an open conformation, proposing GPCR-induced domain closure as the activation mechanism.\",\n      \"evidence\": \"2.6 Å X-ray crystal structure with comparison to GRK2 and dimerization functional assays\",\n      \"pmids\": [\"16613860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor-bound/activated conformation not captured\", \"Direct demonstration of domain closure upon GPCR binding lacking\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Explained receptor-side specificity of recruitment by showing GRK6 requires the CXCR4 C-terminus, and linked this to disease (WHIM syndrome) and chaperone-dependent stability in myeloma.\",\n      \"evidence\": \"Reciprocal co-IP of GRK6/GRK3 with WT vs WHIM-mutant CXCR4 plus β-arrestin/internalization/ERK readouts; GRK6-HSP90 co-IP and siRNA in myeloma\",\n      \"pmids\": [\"19956569\", \"19996089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of C-terminal recognition unknown\", \"Single-lab co-IP for each interaction\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Uncovered a non-GPCR-desensitization function: GRK6-GIT1-Rac1 signaling drives apoptotic-cell engulfment, with loss causing autoimmunity and defective RBC clearance.\",\n      \"evidence\": \"GRK6-KO mice, engulfment and Rac1 activation assays, GRK6-GIT1 co-IP, mass spectrometry, autoimmune phenotyping\",\n      \"pmids\": [\"23443560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRK6 kinase activity is required for GIT1/Rac1 effect not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked GRK6 to CXCR2 regulation in sensory neurons and neuropathic pain, extending its receptor partners to a pain context.\",\n      \"evidence\": \"GRK6-CXCR2 co-IP, immunofluorescence colocalization, lentiviral overexpression with behavioral pain assays in CCI rats\",\n      \"pmids\": [\"27145805\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct CXCR2 phosphorylation assay\", \"Single co-IP with behavioral readout only\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined GRK6 phosphorylation sites on FFA4/GPR120 controlling the balance between β-arrestin recruitment and Gαq/11 calcium signaling.\",\n      \"evidence\": \"GRK6 over/knockdown in HEK293, phosphosite mutagenesis, β-arrestin-2 recruitment and calcium assays\",\n      \"pmids\": [\"24412271\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established a direct non-GPCR substrate, IκBα, placing GRK6 as a positive driver of NF-κB inflammatory transcription downstream of TNF-α.\",\n      \"evidence\": \"In vitro kinase assay on IκBα Ser32/36, kinase-dead mutant, BRET conformational sensor, GRK6-KO macrophages with inflammatory gene readouts\",\n      \"pmids\": [\"25881508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TNF-α routes signal to GRK6 conformational change unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Expanded the in vivo physiological roster (oxytocin receptor desensitization and hematopoietic stem cell maintenance), reinforcing GRK6 as a broad GPCR/kinase regulator.\",\n      \"evidence\": \"GRK6-KO mice with uterine telemetry and β-arrestin/OXTR assays; GRK6-DNA-PKcs co-IP, KO HSC phenotyping with α-lipoic acid rescue\",\n      \"pmids\": [\"26886170\", \"27882944\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DNA-PKcs is a direct GRK6 substrate not established\", \"ROS link to HSC defect indirect\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Distinguished GRK6's role in haptotaxis vs chemotaxis, showing it is essential for directional migration along immobilized CCL21-CCR7 gradients.\",\n      \"evidence\": \"GRK6-KO mice, controlled immobilized gradient assays, live-cell tracking, in vivo migration\",\n      \"pmids\": [\"28457871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for haptotaxis specificity unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified the COMMD3/8 adaptor complex as the determinant of selective GRK6 recruitment to activated chemoattractant receptors, answering how GRK6 is targeted.\",\n      \"evidence\": \"COMMD3/8-GRK6 co-IP, receptor phosphorylation assay, COMMD8/COMMD3-KO mice, B cell migration and humoral immunity readouts\",\n      \"pmids\": [\"31088898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural architecture of the COMMD3/8-GRK6-receptor assembly unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated agonist-selective desensitization of platelet PAR1/PAR4 by GRK6, establishing a hemostatic function and direct receptor binding.\",\n      \"evidence\": \"CRISPR GRK6-KO mice/platelets, GRK6-PAR1 co-IP, PAR1 phosphorylation, signaling and in vivo thrombosis assays\",\n      \"pmids\": [\"31899801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why TxA2 receptor escapes GRK6 regulation unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected palmitoylation-driven membrane translocation to inflammatory PI3K/AKT signaling, generalizing the lipid-modification regulatory theme to innate immunity.\",\n      \"evidence\": \"Acyl-RAC palmitoylation assay, fractionation, immunofluorescence, knockdown/overexpression with PI3K/AKT readouts in Kupffer cells\",\n      \"pmids\": [\"37012861\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GRK6 substrate in PI3K/AKT pathway not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked GRK6 localization to insulin processing and a T2D-associated variant, showing mislocalized hyperactive GRK6-P384S fails to support proinsulin conversion.\",\n      \"evidence\": \"siRNA/inhibitor/rescue in MIN6 cells, proprotein convertase activity, insulin/proinsulin ELISA, mutant localization imaging\",\n      \"pmids\": [\"36030052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GRK6 regulates proprotein convertase expression mechanistically unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Implicated palmitoylation-dependent GRK6 in cancer signaling and metastasis through the β-arrestin2/MAPK/NF-κB axis, and in HIF1α/VHL regulation.\",\n      \"evidence\": \"Palmitoylation-deficient mutant, knockdown/overexpression, migration and in vivo lung colonization assays, pharmacological inhibition (breast cancer); RNAi with HIF1α/VHL readouts (lung adenocarcinoma)\",\n      \"pmids\": [\"39741338\", \"34136390\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrate driving metastatic signaling not defined\", \"VHL-HIF1α link lacks direct biochemical mechanism\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How activated GPCRs convert the open kinase/RGS-H conformation into a closed, catalytically competent state remains structurally undefined, as does the integration of palmitoylation, COMMD3/8 recruitment, and conformational activation into a unified activation cycle.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No receptor-bound GRK6 structure\", \"Activation-cycle ordering of lipid modification, adaptor recruitment, and domain closure unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 15, 16, 22]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 5, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8, 18, 20, 21]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 3, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 23, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 11, 18, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 9, 14, 16, 19, 21]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [3, 11, 20]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"complexes\": [\"COMMD3/8 adaptor complex\"],\n    \"partners\": [\"CXCR4\", \"PAR1\", \"GIT1\", \"COMMD3\", \"COMMD8\", \"HSP90\", \"DNA-PKcs\", \"CXCR2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}